FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095043679> ?p ?o ?g. }

• W2095043679 endingPage "125" @default.
• W2095043679 startingPage "115" @default.
• W2095043679 abstract "Women with hormone dependent breast cancer initially respond to hormone deprivation therapy with tamoxifen or oophorectomy for 12–18 months but later relapse. Upon secondary therapy with aromatase inhibitors, patients often experience further tumor regression. The mechanisms responsible for secondary responses are unknown. We postulated that hormone deprivation induces hypersensitivity to estradiol. Evidence of this phenomenon was provided in a model system involving MCF-7 cells grown in vitro and in xenografts. To determine if the ER transcriptional process is involved in hypersensitivity, we examined the effect of estradiol on ER reporter activity, PgR, PS2, and c-myc as markers and found no alterations in hypersensitive cells. Next, we examined whether MAP kinase may be upregulated in the hypersensitive cells as a reflection of increased growth factor secretion or action. Basal MAP kinase activity was increased both in vitro and in vivo in hypersensitive cells. Proof of principle studies indicated that an increase in MAP kinase activity induced by TGFα administration caused a two- to three-fold shift to the left in estradiol dose response curves in wild type cells. Blockade of MAP kinase with PD98059 returned the shifted curve back to baseline. These data suggested that MAP kinase overexpression could induce hypersensitivity. To determine why MAP kinase was increased, we excluded constitutive receptor activity and growth factor secretion by the demonstration that the pure anti-estrogen, ICI 182780, could inhibit MAP kinase activation. We also excluded hypersensitivity to estradiol induced growth factor secretion, and thus MAP kinase activation, since estradiol stimulated MAP kinase at 24, 48, and 72 h at the same concentrations in hypersensitive as in wild type cells. Surprisingly, a series of experiments suggested that MAP kinase increased in hypersensitive cells as a result of estrogen activation via a non-genomic pathway. We examined the classical signal pathway in which SHC is phosphorylated and binds to SOS and GRB-2 to activate Ras, Raf, and MAP kinase. With 5–20 min of exposure, estradiol caused binding of SHC to the estrogen receptor, phosphorylation of SHC, binding of GRB-2 to SOS, and activation of MAP kinase. All of these affects could be blocked by ICI 182780. Taken together, these observations suggest that the cell membrane ER pathway may be responsible for upregulation of MAP kinase and hypersensitivity in cells adapted to estradiol deprivation." @default.
• W2095043679 created "2016-06-24" @default.
• W2095043679 creator A5000648594 @default.
• W2095043679 creator A5024202469 @default.
• W2095043679 creator A5032896185 @default.
• W2095043679 creator A5035127142 @default.
• W2095043679 creator A5039136616 @default.
• W2095043679 creator A5045354618 @default.
• W2095043679 creator A5048768673 @default.
• W2095043679 creator A5080814125 @default.
• W2095043679 creator A5081817848 @default.
• W2095043679 date "2001-12-01" @default.
• W2095043679 modified "2023-09-24" @default.
• W2095043679 title "Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients" @default.
• W2095043679 cites W1562190372 @default.
• W2095043679 cites W1617062315 @default.
• W2095043679 cites W1934173384 @default.
• W2095043679 cites W1971657539 @default.
• W2095043679 cites W1991322100 @default.
• W2095043679 cites W1998929694 @default.
• W2095043679 cites W2001617382 @default.
• W2095043679 cites W2002809517 @default.
• W2095043679 cites W2005038318 @default.
• W2095043679 cites W2009354488 @default.
• W2095043679 cites W2020220783 @default.
• W2095043679 cites W2027104228 @default.
• W2095043679 cites W2032346433 @default.
• W2095043679 cites W2035120653 @default.
• W2095043679 cites W2035452415 @default.
• W2095043679 cites W2036762576 @default.
• W2095043679 cites W2051508079 @default.
• W2095043679 cites W2053289054 @default.
• W2095043679 cites W2056404763 @default.
• W2095043679 cites W2060874600 @default.
• W2095043679 cites W2061947638 @default.
• W2095043679 cites W2068776651 @default.
• W2095043679 cites W2071708635 @default.
• W2095043679 cites W2072787342 @default.
• W2095043679 cites W2073033285 @default.
• W2095043679 cites W2083117834 @default.
• W2095043679 cites W2098529121 @default.
• W2095043679 cites W2114543718 @default.
• W2095043679 cites W2114712559 @default.
• W2095043679 cites W2118057169 @default.
• W2095043679 cites W2122476299 @default.
• W2095043679 cites W2125437092 @default.
• W2095043679 cites W2166631738 @default.
• W2095043679 cites W2171423946 @default.
• W2095043679 cites W2342218004 @default.
• W2095043679 cites W2603743898 @default.
• W2095043679 cites W4231586639 @default.
• W2095043679 cites W4236399188 @default.
• W2095043679 cites W4237439172 @default.
• W2095043679 cites W4237514360 @default.
• W2095043679 cites W4238175620 @default.
• W2095043679 cites W4238630238 @default.
• W2095043679 cites W4239400520 @default.
• W2095043679 cites W4250537252 @default.
• W2095043679 cites W4252951100 @default.
• W2095043679 cites W4253387338 @default.
• W2095043679 cites W8163034 @default.
• W2095043679 doi "https://doi.org/10.1016/s0960-0760(01)00151-0" @default.
• W2095043679 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11850215" @default.
• W2095043679 hasPublicationYear "2001" @default.
• W2095043679 type Work @default.
• W2095043679 sameAs 2095043679 @default.
• W2095043679 citedByCount "83" @default.
• W2095043679 countsByYear W20950436792012 @default.
• W2095043679 countsByYear W20950436792013 @default.
• W2095043679 countsByYear W20950436792014 @default.
• W2095043679 countsByYear W20950436792015 @default.
• W2095043679 countsByYear W20950436792017 @default.
• W2095043679 countsByYear W20950436792018 @default.
• W2095043679 countsByYear W20950436792019 @default.
• W2095043679 countsByYear W20950436792021 @default.
• W2095043679 countsByYear W20950436792022 @default.
• W2095043679 crossrefType "journal-article" @default.
• W2095043679 hasAuthorship W2095043679A5000648594 @default.
• W2095043679 hasAuthorship W2095043679A5024202469 @default.
• W2095043679 hasAuthorship W2095043679A5032896185 @default.
• W2095043679 hasAuthorship W2095043679A5035127142 @default.
• W2095043679 hasAuthorship W2095043679A5039136616 @default.
• W2095043679 hasAuthorship W2095043679A5045354618 @default.
• W2095043679 hasAuthorship W2095043679A5048768673 @default.
• W2095043679 hasAuthorship W2095043679A5080814125 @default.
• W2095043679 hasAuthorship W2095043679A5081817848 @default.
• W2095043679 hasConcept C121608353 @default.
• W2095043679 hasConcept C126322002 @default.
• W2095043679 hasConcept C134018914 @default.
• W2095043679 hasConcept C184235292 @default.
• W2095043679 hasConcept C2776166826 @default.
• W2095043679 hasConcept C2777164284 @default.
• W2095043679 hasConcept C2777176818 @default.
• W2095043679 hasConcept C530470458 @default.
• W2095043679 hasConcept C71924100 @default.
• W2095043679 hasConcept C86803240 @default.
• W2095043679 hasConcept C95444343 @default.
• W2095043679 hasConceptScore W2095043679C121608353 @default.

• next